GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InhaleRx Ltd (ASX:IRX) » Definitions » Tax Expense

InhaleRx (ASX:IRX) Tax Expense : A$0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is InhaleRx Tax Expense?

InhaleRx's tax expense for the months ended in Jun. 2024 was A$0.00 Mil. Its tax expense for the trailing twelve months (TTM) ended in Jun. 2024 was A$0.00 Mil.


InhaleRx Tax Expense Historical Data

The historical data trend for InhaleRx's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InhaleRx Tax Expense Chart

InhaleRx Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Tax Expense
Get a 7-Day Free Trial - - - - -

InhaleRx Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

InhaleRx Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


InhaleRx  (ASX:IRX) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


InhaleRx Tax Expense Related Terms

Thank you for viewing the detailed overview of InhaleRx's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


InhaleRx Business Description

Traded in Other Exchanges
N/A
Address
126 Phillip Street, Level 5, Sydney, NSW, AUS, 2000
InhaleRx Ltd focuses on medical inhalation devices for the delivery of prescribed medicines. The Medihale Inhaler utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenic often created when combusting plant material such as tobacco or cannabis leaves of flowers. The sealed tamper-proof Medihale Pods provide patients with the additional security that the Medical Cannabis c-liquid is of good quality.

InhaleRx Headlines

No Headlines